Biostax CorpOTC Pink - Limited Information:BTAX
- LAST PRICE0.0225
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.0171/ 192
- Ask / Lots0.0399/ 100
- Open / Previous Close--- / 0.0225
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Biostax Corp | 1.9M | -1.2x | --- |
Bluejay Diagnostics Inc | 1.9M | 0.0x | --- |
Allarity Therapeutics Inc | 1.8M | 0.0x | --- |
Entero Therapeutics Inc | 2.0M | -0.1x | --- |
Kiromic Biopharma Inc | 1.7M | -0.1x | --- |
Dermata Therapeutics Inc | 1.7M | -0.1x | --- |
Company Information
Biostax Corp. is a developer and marketer of pharmaceutical, biotechnology, and MedTech products. The Company has partnerships in the fields of autoimmunity and immune restoration and are able to deliver solutions today for people that are living with autoimmunity, chronic inflammation, infection, and cancer. Its internal and partner programs comprised of JKB-122, an investigational small molecule, long-acting toll-like receptor 4 (TLR4) antagonist developed for autoimmune hepatitis, nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) that has demonstrated anti-fibrotic, immuno-modulating, and anti-inflammatory activities in preclinical models; Lodonal, is a once-a-day immune system regulator for the management of human immunodeficiency virus and acquired immune deficiency syndrome (HIV/AIDS), and LDN, which is a compound formula that is purported to provide immune-modulating benefits that include cancer, pain, autoimmune, and anti-aging.
Contact Information
- Headquarters
- 2431 Aloma Ave #124WINTER PARK, FL, United States 32792
- Phone
- 407-680-3097
- Fax
- 407-641-8668
Executives
- President
- Kelly Wilson
- Chief Executive Officer
- Noreen Griffin
- Chief Financial Officer
- Glen Farmer
- Director
- Mary Clay Reynolds
- Director
- Roger Suro
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.9M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 83.7M |
Biostax Corp does not pay a dividend. | |
Beta | -0.02 |
EPS | $-0.02 |
Book Value | $-0.05 |
P/E Ratio | -1.2x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
